Newswise — Leading healthcare publisher Lippincott Williams & Wilkins (LWW) today announced the release of a groundbreaking, print and electronic version of The Washington Manual of Medical Therapeutics Thirty-Third Edition for fast access at the point-of-care. LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and pharmacy. For the first time, the full content of The Washington Manual of Medical Therapeutics is available by mobile device for one year at no additional charge.
Established for over 65 years as the leading medical textbook, The Washington Manual of Medical Therapeutics is now in its Thirty-Third Edition. This text continues to build upon the proud tradition of The Washington Manual of Medical Therapeutics with even more information, delivered in a timesaving, quick-reference style. Its portability, comprehensiveness, and ease of access make it a favorite on-call resource for house staff, faculty, medical students, and other health care professionals around the world.
For the first time, the full content of this standard-setting reference can also be downloaded to handheld devices for fast, point-of-care access. In addition, the mobile download offers eight medical calculators that include, GFR–Cockcroft-Gault Method (adult); Urea Reduction % (Hemodialysis); Transtubular Potassium Gradient; Serum Osmolal Gap; Serum Anion Gap; Serum Osmolality; Reticulocyte Index; Body Mass Index (BMI). Content updates are also provided throughout the activation period.
“We are proud to offer this latest development in the long history of The Washington Manual. Offering a mobile platform was a natural progression and it clearly reflects how today’s clinician accesses content,” said Thomas M. De Fer, MD, Associate Professor of Internal Medicine at Washington University School of Medicine, St. Louis, MO.
In this new edition, color has been added for better navigation, new decision support algorithms have been added and an improved template and bulleted format have been implemented to facilitate quicker access to evidence-based management recommendations.
For more information or to purchase, contact Lippincott Williams & Wilkins at 1-800-638-3030 or visit www.lww.com.
The Washington Manual™ is a registered mark belonging to Washington University in St. Louis to which international legal protection applies. The mark is used in this publication by LWW under license from Washington University.
About Lippincott Williams & Wilkins Lippincott Williams & Wilkins (LWW) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1,500 books in more than 100 disciplines publishing under the LWW brand, as well as content-based sites and online corporate and customer services.
LWW is part of Wolters Kluwer Health (www.wolterskluwerhealth.com), a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons®; and electronic information providers, such as Ovid®, UpToDate®, Medi-Span® and ProVation® Medical.
Wolters Kluwer Health is part of Wolters Kluwer (www.wolterskluwer.com), a market-leading global information services company. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare rely on Wolters Kluwer’s leading, information-enabled tools and solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer has 2009 annual revenues of €3.4 billion ($4.8 billion), employs approximately 19,300 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.
RSS